Menstrual Cycle Cycle Disorders

Pathophysiology of heavy menstrual bleeding

Hapangama DK, Bulmer JN

Published January 2016 Women's health (London, England), 12(1), 3-13
DOI 10.2217/whe.15.81 PMID 26695831 PMC PMC5779569

RRM Academy Synopsis

Heavy menstrual bleeding has many structural and hormonal causes

A 2016 narrative review of heavy menstrual bleeding (HMB) reports that up to 30% of women in developed countries bleed heavily, and causes include fibroids, polyps, missed ovulation and clotting disorders. The authors sort the causes by the PALM-COEIN system.

Key Findings

  • The authors report that excessive bleeding, termed HMB, affects as many as 20–30% of women in the developed world.
  • Von Willebrand disease was diagnosed in the laboratory in as many as 13% of women who presented with HMB.
  • Among 985 symptomatic women at a gynecology clinic, ultrasound found adenomyosis in 20.9%, and the ultrasound diagnosis correlated well with histology in the 45 women who later had a hysterectomy.
  • One in three women in the perimenopausal years have HMB, while it is relatively uncommon in younger women.

Interpretation

The narrative review examines how heavy menstrual bleeding arises, drawing on laboratory, imaging and tissue studies. The review discusses fibroids, adenomyosis, polyps, hyperplasia, clotting disorders and missed ovulation as causes. For fibroids, the authors find no consistent link between size or location and bleeding. The authors state that understanding of menstrual bleeding is incomplete.

RRM Context

The review states that normal bleeding depends on the lining being exposed to estrogen, then progesterone, then a drop in progesterone. That sequence depends on ovulation. Cycles without ovulation, PCOS (also called PMOS, Polyendocrine Metabolic Ovarian Syndrome) and obesity can lead to long unopposed estrogen and heavy bleeding. Restorative reproductive medicine starts from this biology when it looks for the cause of heavy periods.

Abstract

Heavy menstrual bleeding (HMB) is a common gynecological complaint with multiple etiologies and diverse pathophysiological origins. This review discusses HMB with reference to the recently proposed PALM-COEIN classification system for abnormal uterine bleeding, initially describing the endometrial events in normal menstruation followed by discussion of the perturbations of normal endometrial shedding that can result in HMB. Our present understanding of the mechanisms of menstrual bleeding as well as many of the pathological aberrations of HMB is incomplete. Further research into the pathophysiology of HMB is urgently needed, as clear knowledge of the mechanisms of this disorder will provide new therapeutic targets to formulate more effective treatments.

Topics

By this author

Related research

Menstrual Cycle › Cycle Disorders › Abnormal Uterine Bleeding
Dharani K Hapangama, Judith N Bulmer
D Hapangama, J Bulmer
PMID 26695831 26695831 DOI 10.2217/whe.15.81 10.2217/whe.15.81 Hapangama et al. 2016, Hapangama 2016